A deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses

Microbiology and Immunology

Volumn 55, Issue 12, 2011, Pages 847-854

  Sisti, Federico ^a   Fernández, Julieta ^a   Higgins, Sarah C ^c   Casabuono, Adriana ^b   Couto, Alicia ^b   Mills, Kingston H G ^c   Hozbor, Daniela ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bordetella bronchiseptica; Deep rough mutant; LPS

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 10; LIPID A; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BORDETELLA BRONCHISEPTICA; BORDETELLA BRONCHISEPTICA INFECTION; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LUNG INFECTION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; WILD TYPE;

ANIMALS; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; CYTOKINES; FEMALE; LIPID A; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MUTATION; O ANTIGENS; RESPIRATORY TRACT INFECTIONS; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; MUS;

EID: 84855249301     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00395.x     Document Type: Article

References (30)

1. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Di Padova F. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8:217-25.
2. Trent M.S., Stead C.M., Tran A.X., Hankins J.V. (2006). Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res 12: 205-23.
3. Loppnow H., Brade H., Dürrbaum I., Dinarello C.A., Kusumoto S., Rietschel E.T. (1989) Flad HDIL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 142:3229-38.
4. Harvey H.A., Swords W.E, Apicella M.A. (2001) The mimicry of human glycolipids and glycosphingolipids by the lipooligosaccharides of pathogenic neisseria and haemophilus. J Autoimmun 16:257-62.
5. Maskell D.J., Szabo M.J, Butler P.D., Williams A.E., Moxon E.R. (1991) Phase variation of lipopolysaccharide in Haemophilus influenzae. Res Microbiol 142:719-24.
6. de Vries F.P., van Der Ende A., van Putten J.P., Dankert J. (1996) Invasion of primary nasopharyngeal epithelial cells by Neisseria meningitidis is controlled by phase variation of multiple surface antigens. Infect Immun 64:2998-3006.
7. Mann P.B., Kennett M.J., Harvill E.T. (2004) Toll-like receptor 4 is critical to innate host defense in a murine model of bordetellosis. J Infect Dis 189: 833-6.
8. Caroff M., Aussel L., Zarrouk H., Martin A., Richards J.C., Thérisod H., Perry M.B., Karibian D. (2001). Structural variability and originality of the Bordetella endotoxins. J EndotoxinRes 7: 63-8.
9. MacArthur I., Mann P.B., Harvill E.T., Preston A. (2007) IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. J Endotoxin Res 13: 243-7.
10. Sisti F., Fernández J., Rodríguez M.E., Lagares A., Guiso N., Hozbor D.F. (2002). In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure. Infect Immun 70: 1791-8.
11. Stainer D.W., Scholte M.J. (1970). A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 63: 211-20.
12. Fernández J., Sisti F., Bottero D., Gaillard M.E., Hozbor D. (2005) Constitutive expression of bvgR-repressed factors is not detrimental to the Bordetella bronchiseptica-host interaction. Res Microbiol 156: 843-50.
13. Darveau R.P., Hancock R.E. (1983) Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155: 831-8.
14. Preston A., Petersen B.O., Duus J.Ø., Kubler-Kielb J., Ben-Menachem G., Li J., Vinogradov E. (2006) Complete structures of Bordetella bronchiseptica and Bordetella parapertussis lipopolysaccharides. J Biol Chem 281: 18135-44.
15. Rumbo M., Sierro F., Debard N., Kraehenbuhl J.P., Finke D. (2004) Lymphotoxin beta receptor signaling induces the chemokine CCL20 in intestinal epithelium. Gastroenterology 127: 213-23.
16. Ross P.J., Lavelle E.C., Mills K.H.G., Boyd A.P. (2004) Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun 72: 1568-79.
17. Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., Miller S.I. (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276(5310): 250-53.
18. Rosner M.R., Tang J., Barzilay I., Khorana H.G. (1979) Structure of the lipopolysaccharide from an Escherichia coli heptose-less mutant. I. Chemical degradations and identification of products. J Biol Chem 254(13): 5906-17.
19. Jones J.W., Shaffer S.A., Ernst R.K., Goodlett D.R., Turecek F. (2008) Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approach. Proc Natl Acad Sci U S A 105(35): 12742-7.
20. Zanonia, I and Granucci F. (2010) Differences in lipopolysaccharide-induced signaling between conventional dendritic cells and macrophages. Immunobiology 215: 709-12.
21. Foster S.L., Medzhitov R. (2009) Gene-specific control of the TLR-induced inflammatory response. Clin Immunol 130: 7-15.
22. Buboltz A.M., Nicholson T.L., Karanikas A.T., Preston A., Harvill E.T. (2009) Evidence for horizontal gene transfer of two antigenically distinct O antigens in Bordetella bronchiseptica. Infect Immun 77: 3249-57.
23. Gueirard P., Le Blay K., Le Coustumier A., Chaby R., Guiso N. (1998) Variation in Bordetella bronchiseptica lipopolysaccharide during human infection. FEMS Microbiol Lett 162: 331-7.
24. Vinogradov E., King J.D., Pathak A.K., Harvill E.T., Preston A. (2010) Antigenic Variation among Bordetella: Bordetella bronchiseptica strain MO149 expresses a novel O chain that is poorly immunogenic. J Biol Chem 285: 26869-77.
25. Harvill E.T., Preston A., Cotter P.A., Allen A.G., Maskell D.J., Miller J.F. (2000) Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun 68: 6720-8.
26. Preston A., Maxim E., Toland E., Pishko E.J., Harvill E.T., Caroff M., Maskell D.J. (2003) Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol Microbiol 48: 725-36.
27. Cotter P.A., Miller J.F. (1994) BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun 62: 3381-90.
28. Inatsuka C.S., Xu Q., Vujkovic-Cvijin I., Wong S., Stibitz S., Miller J.F, Cotter P.A. (2010) Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Infect Immun 78: 2901-9.
29. Baldridge J.R., McGowan P., Evans J.T., Cluff C., Mossman S., Johnson D., Persing D. (2004) Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther 4: 1129-38.
30. Gangloff M., Gay N.J. (2004) MD-2: the Toll «gatekeeper» in endotoxin signalling. Trends Biochem Sci 29: 294-300.